Inventor

SMITH JEFFREY T L

US106 patents

⚠️ This page may combine multiple inventors who share the name “SMITH JEFFREY T L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SMITH JEFFREY T L

ALDERBIO HOLDINGS LLC

Antibodies to IL-6 and use thereof

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

Antagonists of IL-6 to raise albumin and/or lower CRP

Method of improving patient survivability and quality of life by administering an anti-IL-6 antibody

Antibodies to IL-6 to inhibit or treat inflammation

Anti-IL-6 antibodies for the treatment of oral mucositis

Antibodies to IL-6 and use thereof

Method of treating allergic asthma with antibodies to IL-6

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

Antagonists of IL-6 to prevent or treat thrombosis

Anti-IL-6 antibody for use in the treatment of cachexia

Treating anemia in chronic IL-6 associated diseases using anti-IL-6 antibodies

Isolated anti-IL-6 antibodies

Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibody

Method of improving patient survivability and quality of life by anti-IL-6 antibody administration

Antagonists of IL-6 to raise albumin and/or lower CRP

Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or fever

Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia

Antibodies to IL-6 and use thereof

SMITH JEFFREY T L

Antagonists of IL-6 to prevent or treat thrombosis

Antagonists of IL-6 to prevent or treat thrombosis

Methods of treating anemia using anti-IL-6 antibodies

Anti-IL-6 antibodies for the treatment of arthritis

Antagonists of IL-6 to prevent or treat thrombosis

Methods of reducing CRP and/or increasing serum albumin in patients in need using IL-6 antibodies of defined epitopic specificity

Antagonists of IL-6 to raise albumin and/or lower CRP

Antagonists of IL-6 to raise albumin and/or lower CRP

Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity

Anti-IL-6 antibodies for the treatment of oral mucositis

Antagonists of IL-6 to prevent or treat thrombosis

H LUNDBECK AS

Acute treatment and rapid treatment of headache using anti-CGRP antibodies

Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion

Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies

Humanized anti-PACAP antibodies

Humanized anti-PACAP antibodies

Humanized anti-PACAP antibodies

GARCIA-MARTINEZ LEON

Antibodies to IL-6 and use thereof

Use of anti-IL-6 antibodies having specific binding properties to treat cachexia

Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies

Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments

Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity

ALDER BIOPHARMACEUTICALS INC

Anti-PACAP antibodies and uses thereof

Humanized anti-PACAP antibodies and uses thereof

Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversion

RUSSO ANDREW F

Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels

Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers

LATHAM JOHN A

Methods of preventing or treating pain using anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75

GARCIA-MARTINEZ LEON F

Methods of preventing or treating pain using anti-NGF antibodies

H LUNDBECK

Treatment of headache using anti-CGRP antibodies